These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 31190812

  • 1. Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
    Chen M, Wang L, Wang F, Li F, Xia W, Gu H, Chen Y.
    Int J Nanomedicine; 2019; 14():3557-3569. PubMed ID: 31190812
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J, Fang X, Hao J, Sha X.
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation.
    Misra R, Das M, Sahoo BS, Sahoo SK.
    Int J Pharm; 2014 Nov 20; 475(1-2):372-84. PubMed ID: 25178825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk.
    Bhattacharjee M, Ghosh A, Das S, Sarker S, Bhattacharya S, Das A, Ghosh S, Chattopadhyay S, Ghosh S, Adhikary A.
    ACS Biomater Sci Eng; 2024 Oct 14; 10(10):6314-6331. PubMed ID: 39285678
    [Abstract] [Full Text] [Related]

  • 9. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
    Li JM, Zhang W, Su H, Wang YY, Tan CP, Ji LN, Mao ZW.
    Int J Nanomedicine; 2015 Oct 14; 10():3147-62. PubMed ID: 25960653
    [Abstract] [Full Text] [Related]

  • 10. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X, Zhao Y, Ng KW, Zhao Y.
    Chemistry; 2013 Nov 11; 19(46):15593-603. PubMed ID: 24123533
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
    Zhang Z, Xu S, Wang Y, Yu Y, Li F, Zhu H, Shen Y, Huang S, Guo S.
    J Colloid Interface Sci; 2018 Jan 01; 509():47-57. PubMed ID: 28881205
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail.
    Wang S, Liu X, Chen S, Liu Z, Zhang X, Liang XJ, Li L.
    ACS Nano; 2019 Jan 22; 13(1):274-283. PubMed ID: 30566319
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reversal of Chemoresistance via Staged Liberation of Chemodrug and siRNA in Hierarchical Response to ROS Gradient.
    Dang J, Li Y, Yan J, Wu J, Cai K, Yin L, Zhou Z.
    Adv Healthc Mater; 2024 Jun 22; 13(15):e2304130. PubMed ID: 38427696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.